Dynavax's Strategy is Delivering Significant Long-Term Stockholder ValueDynavax's Nominees Are Vastly Superior to Deep Track's Candidates Across Every Critical AreaFollow Recommendations of Proxy Advisory Firms ISS and Egan-Jones and Vote "FOR" All Four of Dynavax's Director Nominees on the GOLD Proxy Card TodayEMERYVILLE, Calif., June 9, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and commercializ ...